Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A special committee investigation by the relevant institutions found that Leen Kawas (first author on Benoist 2014, co-author on McCoy 2013, and at the time CEO of the biotech commercializing a Dihexa derivative) had altered images in her doctoral dissertation and at least four published research papers from the Harding laboratory between approximately 2008 and 2012
The benefits described are based on third-party studies
Oz has raved about this little miracle ingredient on his daytime TV show
Genome-wide association study of Parkinsons disease in East Asians
Great really works So far, the product has been effective
BPC-157 is not FDA-approved for human therapeutic use and is classified as a Category 2 bulk drug substance by the FDA
